National Institutes of Health · ABD

Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science

Ön duyuru — henüz açık değil

Bu bir ön duyurudur: fon sağlayıcı fırsatı duyurdu ancak henüz başvuruya açık değil, tahmini son tarih 25 Ocak 2027. Uygun başvuru sahibi türleri (kaynakta): Others (see text field entitled "Additional Information on Eligibility" for clarification).

Son başvuru: Tahmini 25 Ocak 2027 (henüz kesin değil)
Hibe tutarı: Belirtilmemiş — resmi çağrıya bakın
Destek oranı: Zorunlu eş finansman belirtilmemiş; destek oranı belirtilmemiş
Eş finansman: Gerekli değil
Fon sağlayıcı: National Institutes of Health
Referans: PAR-28-006
Destek listesi (ABD): 93.350 National Center for Advancing Translational Sciences
Son kontrol: 15 Kasım 2026

Resmi çağrıyı aç ↗

Resmi açıklamalar fon sağlayıcının dilindedir (çoğunlukla İngilizce); bu sayfadaki özet ve temel bilgiler Türkçedir.

Çağrı hakkında

The purpose of the Congressionally mandated Clinical and Translational Science Award (CTSA) Program is to accelerate the translation of scientific discoveries into treatments, diagnostics, and health interventions that improve patient and public health by funding and coordinating a national network of academic medical centers that provide the infrastructure, expertise, training, and collaboration needed to move discoveries from the laboratory into clinical practice and community health. The purpose of the High Impact Specialized Innovation Programs (SIPs) is to support the development and demonstration of unique hub capabilities, research platforms and/or resources to address in a timely manner critical gap areas and/or roadblocks in clinical and translational science at awarded CTSA Program Hubs.

Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

Tam metni oku

This is a Forecast for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.

Kimler başvurabilir

Others (see text field entitled "Additional Information on Eligibility" for clarification)

Başvuru sahibi kategorileri yalnızca bir başlangıç noktasıdır. Uygunluğa resmi çağrı karar verir.

Konular

Health

Nasıl başvurulur

Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply: Not stated in the call text we hold — check the official page
Company stage: Not stated in the call text we hold — check the official page
Single applicant or consortium: Not stated in the call text we hold — check the official page
Where applicants must be based: Not stated in the call text we hold — check the official page
Where to apply: Not stated in the call text we hold — check the official page

İletişim

Division of Clinical Innovation, NCATS · RC2NOFO@nih.gov · Please contact via e-mail.

Resmi kaynaklar

Resmi çağrı sayfası

Bu sayfadaki bilgiler resmi kaynaktan alınmıştır ve en son 15 Kasım 2026 tarihinde kontrol edilmiştir. Sonraki değişiklikler dahil, fon sağlayıcının kendi belgeleri her zaman önceliklidir.